Murata, Miho
Mihara, Masahito
Hasegawa, Kazuko
Jeon, Beomseok
Tsai, Chon-Haw
Nishikawa, Noriko
Oeda, Tomoko
Yokoyama, Masayuki
Robieson, Weining Z
Ryman, Davis
Eaton, Susan
Chatamra, Krai
Benesh, Janet
Article History
Received: 11 April 2016
Revised: 1 July 2016
Accepted: 23 August 2016
First Online: 3 November 2016
Competing interests
: Mi.M., Ma.M., K.H., C-H.T., N.N., and T.O. were study investigators and received research support from AbbVie. BJ was a study investigator and received research support from the Ministry of Health and Welfare, Seoul National University Hospital, Sinyang Cultural Foundation, Song Foundation, Korean Movement Disorder Society, Samil Pharmaceuticals, AbbVie Korea, UCB Korea, Ipsen Korea, Sandoz Korea, Lundbeck Korea, Novartis Korea; travel support from Korea Research-Based Pharmaceutical Industry Association, Korean Pharmaceutical Manufacturers Association, Seoul National University, Seoul National University Hospital; and compensation from Lundbeck Korea for consulting and Ipsen and UCB for speaking. M.Y., W.Z.R., D.R., K.C., and J.B. are employees of AbbVie and may hold stock or stock options. S.E. is a former employee of AbbVie and may hold stock or stock options.